In the GRN mutation carrier group, no differences were observed in plasma PGRN concentrations between patients with a diagnosis of behavioural variant FTD (bvFTD) and those with a primary progressive aphasia (PPA) (Supplementary Fig. 4). The gene discussed is GRN; the disease is primary progressive aphasia.